Jackson Andrew C. 4
4 · Calidi Biotherapeutics, Inc. · Filed Aug 25, 2025
Insider Transaction Report
Form 4
Jackson Andrew C.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-08-21$2.00/sh+2,500$5,000→ 2,500 total - Purchase
Warrant (right to buy)
2025-08-21+2,500→ 2,500 totalExercise: $2.00From: 2025-08-21Exp: 2030-08-21→ Common stock (2,500 underlying)
Footnotes (2)
- [F1]The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025.
- [F2]Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant.